ATTACHMENTS / EXHIBITS

primary_doc.xml

ANNUAL REPORT

CERTIFICATE OF AMENDMENT TO SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF 20/20 BIOLABS, INC

CERTIFICATE OF DESIGNATION OF SERIES D PREFERRED STOCK

WARRANT TO PURCHASE COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO DAVID B. FRIEMAN ON APRIL 19, 2022

WARRANT TO PURCHASE COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO STARTENGINE PRIMARY, LLC ON DECEMBER 31, 2021

WARRANT TO PURCHASE COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO STARTENGINE PRIMARY, LLC ON DECEMBER 31, 2020

FORM OF CONVERTIBLE PROMISSORY NOTE

LICENSE AGREEMENT, DATED FEBRUARY 14, 2025, BETWEEN 20/20 BIOLABS, INC. AND CONNECTING HEALTH INNOVATIONS

PARTICIPATION AGREEMENT, DATED JANUARY 6, 2025, BETWEEN 20/20 BIOLABS, INC. AND AHOLD DELHAIZE USA SERVICES LLC

AMENDED AND RESTATED STATEMENT OF WORK NO. 2, DATED JANUARY 6, 2025, BETWEEN 20/20 BIOLABS, INC. AND AHOLD DELHAIZE USA SERVICES LLC